PABD Holdings Information

Compare

Holdings Count

421

Total Assets

317.93M

Top 10 Percentage

14.41%

Asset Class

Equity

Top Holdings

421 Holdings as of May 08, 2026

ASML

ASML Holding NV

2.90%

$9.28M

―

€503.99B

110.43%

16 Buy

2 Hold

0 Sell

Strong Buy

―

NOVN

Novartis

1.44%

$4.60M

―

CHF206.95B

24.69%

6 Buy

6 Hold

2 Sell

Moderate Buy

―

Royal Bank Of Canada

1.40%

$4.48M

―

$254.17B

51.05%

10 Buy

2 Hold

0 Sell

Strong Buy

―

ABBN

Abb Ltd (UK)

1.40%

$4.47M

―

CHF147.66B

81.83%

1 Buy

10 Hold

0 Sell

Hold

―

HSBA

Hsbc Holdings Plc (UK)

1.36%

$4.36M

―

£226.79B

55.42%

8 Buy

8 Hold

0 Sell

Moderate Buy

―

Schneider Electric SE (UK)

1.33%

$4.26M

―

€153.54B

26.79%

12 Buy

0 Hold

0 Sell

Strong Buy

―

ROP

Roche Holding

1.31%

$4.20M

―

$323.93B

32.62%

6 Buy

6 Hold

1 Sell

Moderate Buy

―

AZN

AstraZeneca plc

1.31%

$4.18M

―

£206.95B

30.31%

13 Buy

1 Hold

1 Sell

Strong Buy

―

Toronto Dominion Bank

0.99%

$3.17M

―

$181.61B

70.08%

7 Buy

4 Hold

1 Sell

Moderate Buy

―

6857

Advantest Corp

0.97%

$3.12M

―

$133.07B

309.14%

8 Buy

3 Hold

0 Sell

Moderate Buy

―

Rows:

PABD ETF News

PremiumThe Fly

Entrada Therapeutics price target lowered to $10 from $19 at Roth Capital

1d ago

NVS

TRDA

PremiumThe Fly

HSBC price target raised to 1,370 GBp from 1,360 GBp at JPMorgan

1d ago

HSBC

PremiumBlurbs

Citic Securities Reaffirms Their Buy Rating on HSBC Holdings (HSBA)

2d ago

HSBC

PremiumBlurbs

CICC Keeps Their Buy Rating on HSBC Holdings (HSBA)

2d ago

HSBC

See More PABD News

PABD ETF FAQ

What are ETF PABD’s top 3 holdings?

PABD’s top 3 holdings are NL:ASML, CH:NOVN, TSE:RY.

What is ETF PABD’s holdings count?

ETF PABD’s is holdings 421 different assets.

What are the total assets of ETF PABD?

ETF PABD’s total assets are 317.93M.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing